People living with HIV in congregate settings,

People living with HIV in congregate settings,
such as prisons and centres for refugees or
internally displaced persons, have a higher
risk for and incidence of TB, HIV infection and drug
use.[2] Special attention has to be paid to ensure
screening for TB and provision of IPT for these groups.
Injecting drug users have a higher risk of coinfections
with HIV, TB and hepatitis causing viruses. Screening
for TB and providing IPT for injecting drug users
should be combined with harm reduction measures,
including the provision of testing for hepatitis B and
hepatitis C infection, and referral for positive cases.
[28] Sound clinical judgement is required to weigh
the benefits of IPT among injecting drug users with
hepatitis coinfection. IPT should not be provided in
the presence of active hepatitis.